Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseasesLeon A Adams, Quentin M Anstee, Herbert Tilg, Giovanni Targher
17 March 2017
Dietary and pharmacological treatment of abdominal pain in IBSMichael Camilleri, Guy Boeckxstaens
23 February 2017
Novel insight into the role of microbiota in colorectal surgeryRadu Bachmann, Daniel Leonard, Nathalie Delzenne, Alex Kartheuser, Patrice D Cani
2 February 2017
Acute-on-chronic liver failure: an updateRuben Hernaez, Elsa Solà, Richard Moreau, Pere Ginès
4 January 2017
Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?Sreedhar Subramanian, Anders Ekbom, Jonathan M Rhodes
6 October 2016
Current and upcoming pharmacotherapy for non-alcoholic fatty liver diseaseYaron Rotman, Arun J Sanyal
19 September 2016
Expert opinions and scientific evidence for colonoscopy key performance indicatorsColin J Rees, Roisin Bevan, Katharina Zimmermann-Fraedrich, Matthew D Rutter, Douglas Rex, Evelien Dekker, Thierry Ponchon, Michael Bretthauer, Jaroslaw Regula, Brian Saunders, Cesare Hassan, Michael J Bourke, Thomas Rösch
8 October 2016
Antibiotics as deep modulators of gut microbiota: between good and evilGianluca Ianiro, Herbert Tilg, Antonio Gasbarrini
16 August 2016
Role of bismuth in improving Helicobacter pylori eradication with triple therapyMaria Pina Dore, Hong Lu, David Y Graham
4 February 2016
GLP-1 based therapies: clinical implications for gastroenterologistsMark M Smits, Daniel H van Raalte, Lennart Tonneijck, Marcel H A Muskiet, Mark H H Kramer, Djuna L Cahen
19 January 2016